NANDROLONE DECANOATE Drug Patent Profile
✉ Email this page to a colleague
When do Nandrolone Decanoate patents expire, and when can generic versions of Nandrolone Decanoate launch?
Nandrolone Decanoate is a drug marketed by Abraxis Pharm, Am Regent, Epic Pharma Llc, and Watson Labs. and is included in ten NDAs.
The generic ingredient in NANDROLONE DECANOATE is nandrolone decanoate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone decanoate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NANDROLONE DECANOATE?
- What are the global sales for NANDROLONE DECANOATE?
- What is Average Wholesale Price for NANDROLONE DECANOATE?
Summary for NANDROLONE DECANOATE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 61 |
| Clinical Trials: | 11 |
| Patent Applications: | 1,335 |
| DailyMed Link: | NANDROLONE DECANOATE at DailyMed |
Recent Clinical Trials for NANDROLONE DECANOATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | Phase 2 |
| Medical Research Agency, Poland | Phase 2 |
| King Edward Medical University | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for NANDROLONE DECANOATE
US Patents and Regulatory Information for NANDROLONE DECANOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 088290-001 | Oct 3, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 088554-001 | Feb 10, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 087519-001 | Sep 28, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 086598-001 | Jan 13, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abraxis Pharm | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 088317-001 | Oct 14, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Am Regent | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 091252-001 | Aug 30, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
